Israeli based company Oramed Pharmaceuticals Inc says they conducted successful trials on oral insulin for midstage type ii diabetes (T2D) patients. Their oral insulin successfully reduced nighttime blood glucose levels. No side effects such as dangerously low blood sugar reported. 90% of the diabetes patients are of type 2 diabetes (T2D). The insulin pill will have a protective coating and a high-enough dose of insulin and is much closer to natural insulin. The tested oral insulin goes from the gut to liver but injected insulin goes from blood to liver. High levels of insulin circulating inside the body increase health risks. The new drug will be known as ORMD-0801.
A study was conducted by Thomas O. Mundinger, from the University of Washington in Seattle, to check early and severe loss of islet sympathetic nerves in diabetes. According to a study published online in Diabetes, it was found that marked and sustained loss of islet sympathetic nerves were found in type 1 diabetes (T1D). There was no loss in type 2 diabetes (T2D).
Diabetic ketoacidosis is a serious complication of diabetes that occurs when your body produces high levels of blood acids called ketones. When the human body produces more blood acids (ketones), then the body gets serious complication called diabetic ketoacidosis. During this time, our body can't produce enough insulin. Insulin helps energy entering into cells.
According to Diabetes Technology & Therapeutics (DTT), published in Liebertpub, insulin pump therapy is a developing technology and one can control blood glucose in type 1 diabetes (T1D) and type 2 diabetes (T2D) in a better way. Now current technology pumps are much smaller and can be operated remotely by smartphones.
There are wireless devices in the market to measure blood glucose via Bluetooth connectivity made by Ascensia Diabetes Care under the trademark CONTOUR NEXT ONE and CONTOUR PLUS ONE. The devices give instant feedback on blood glucose results, reminders and alerts. The above devices were approved by CE Mark.
Scientists and researchers from Cardiff University Institute of Infection & Immunity found germs that destroy the cells which produce insulin. Previously scientists found that T-cells, one type of white blood cell in our body, extremely effective in protecting us from germs. The same T-cells activated by bacteria play a major part in destroying insulin producing beta cells. Germs trigger body's immune system to destroy cells that produce insulin. The behavior of T-cells of our body is like a friendly fighting or mistaken identity as they are unnecessarily fighting with the beta cells. Scientists hope that further research will lead us to the prevention of type 1 diabetes (T1D). Even children suffer from type 1 diabetes (T1D) and it is not connected with diet. The research was published in The Journal of Clinical Investigation.
5% of the type 1 diabetes (T1D) children die in their sleep this is known as "dead in bed syndrome". Warning signs for diabetes in children are
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.